Natixis Advisors, L.P. Corcept Therapeutics Inc Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 32,123 shares of CORT stock, worth $2.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,123
Previous 28,144
14.14%
Holding current value
$2.34 Million
Previous $1.3 Million
24.25%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CORT
# of Institutions
403Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$736 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$589 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$451 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$278 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.79B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...